Xeroderma Pigmentosum with Central and Peripheral Nervous System Abnormalities

Patients diagnosed with xeroderma pigmentosum (XP) may present with involvement of both the central and peripheral nervous systems — including those meeting criteria for XP/CS complex. Neurological complications significantly shape prognosis and require a management approach tailored to this specific clinical picture.

Clinical scenario

In many XP patients, the diagnosis is complicated by central and peripheral nervous system abnormalities, including psychomotor retardations whose progression and severity directly influence prognosis. Patients identified as having XP/CS complex are managed in accordance with guidelines specific to XP neurological disease.

Treatment approach

When neuromuscular complications arise and affect the upper and lower extremities, a targeted pharmacological intervention may be appropriate to support patient care. The specific approach depends on the clinical presentation and is detailed in the full structured protocol.

The complete regimen — including selection criteria and clinical decision points — is available via the link below.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1111/1346-8138.13907

In the majority of Japanese patients, XP is complicated with abnormalities in the central and peripheral nervous systems, such as psychomotor retardations of which progression and severity greatly influence the prognosis.
If the patient is diagnosed with XP/CS complex, conform to the guidelines for XP neurological disease.
If muscle tonus of the upper and lower extremities is worsened and nursing seems to be hard, treatment with botulinum toxin might be considered.

View source ↗